Clinical Utility of the 21-gene assay in Predicting Response to Neoadjuvant Endocrine Therapy in Breast Cancer: A Systematic Review and Meta-Analysis

被引：0
|
作者：
Kerin, Eoin [1 ]
Davey, Matthew [1 ]
Ryan, Eanna [1 ]
Boland, Michael [1 ]
Barry, Michael [1 ]
Lowery, Aoife [1 ]
Kerin, Michael [1 ]
机构：
[1] Univ Galway, Dept Surg, Lambe Inst Translat Res, Galway, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2024年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
24
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 50 条
  • [21] Unlocking the potential of circulating miRNAs in predicting response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis
    Tiberio, P.
    Gaudio, M.
    Belloni, S.
    Benvenuti, C.
    Jacobs, F.
    Saltalamacchia, G.
    Zambelli, A.
    Santoro, A.
    De Sanctis, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S301 - S301
  • [22] THE 21-GENE BREAST CANCER ASSAY: SUMMARY OF CLINICAL EVIDENCE
    Sing, A. P.
    Baehner, F. L.
    Yoshizawa, C.
    Butler, S. M.
    Tharayanil, A.
    Shak, S.
    Burke, E.
    BREAST, 2013, 22 : S65 - S66
  • [23] Meta-Analysis of the Decision Impact of the 21-Gene Breast Cancer Recurrence Score in Clinical Practice
    Hornberger, J.
    Chien, R.
    CANCER RESEARCH, 2010, 70
  • [24] Neoadjuvant chemotherapy combined with endocrine therapy for hormone receptor-positive breast cancer: A systematic review and meta-analysis
    Ma, Hong-Fang
    Shen, Jun
    Xu, Bin
    Shen, Jian-Guo
    MEDICINE, 2023, 102 (46)
  • [25] Concurrent neoadjuvant endocrine therapy with chemotherapy in HR+HER2-breast cancer: a systematic review and meta-analysis
    Wu, Ping
    Lv, Wenjie
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [26] Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HP2-Early Breast Cancer
    Nitz, Ulrike A.
    Gluz, Oleg
    Kuemmel, Sherko
    Christgen, Matthias
    Braun, Michael
    Aktas, Bahriye
    Luedtke-Heckenkamp, Kerstin
    Forstbauer, Helmut
    Grischke, Eva-Maria
    Schumacher, Claudia
    Darsow, Maren
    Krauss, Katja
    Nuding, Benno
    Thill, Marc
    Potenberg, Jochem
    Uleer, Christoph
    Warm, Mathias
    Fischer, Hans Holger
    Malter, Wolfram
    Hauptmann, Michael
    Kates, Ronald E.
    Graeser, Monika
    Wuerstlein, Rachel
    Shak, Steven
    Baehner, Frederick
    Kreipe, Hans H.
    Harbeck, Nadia
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (23) : 2557 - +
  • [27] Decision-making impact on adjuvant chemotherapy allocation in early node-negative breast cancer with a 21-gene assay: systematic review and meta-analysis
    Augustovski, Federico
    Soto, Natalie
    Caporale, Joaquin
    Gonzalez, Lucas
    Gibbons, Luz
    Ciapponi, Agustin
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (03) : 611 - 625
  • [28] Decision-making impact on adjuvant chemotherapy allocation in early node-negative breast cancer with a 21-gene assay: systematic review and meta-analysis
    Federico Augustovski
    Natalie Soto
    Joaquín Caporale
    Lucas Gonzalez
    Luz Gibbons
    Agustín Ciapponi
    Breast Cancer Research and Treatment, 2015, 152 : 611 - 625
  • [29] The Value of Tumor Infiltrating Lymphocytes (TILs) for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
    Mao, Yan
    Qu, Qing
    Zhang, Yuzi
    Liu, Junjun
    Chen, Xiaosong
    Shen, Kunwei
    PLOS ONE, 2014, 9 (12):
  • [30] Cost-utility analysis of 21-gene assay for node-positive early breast cancer
    Masucci, L.
    Torres, S.
    Eisen, A.
    Trudeau, M.
    Tyono, I
    Saunders, H.
    Chan, K. W.
    Isaranuwatchai, W.
    CURRENT ONCOLOGY, 2019, 26 (05) : 307 - 318
12345